Schoeler, NE 
ORCID: https://orcid.org/0000-0001-6202-1497, Simpson, Z, Whiteley, VJ, Nguyen, P, Meskell, R, Lightfoot, K, Martin-McGill, KJ, Olpin, S and Ivison, F ORCID: https://orcid.org/0000-0003-2087-6870
2020,
'Biochemical assessment of patients following ketogenic diets for epilepsy : current practice in the UK and Ireland'
, Epilepsia Open, 5 (1)
, pp. 73-79.
|
PDF
- Published Version
Available under License Creative Commons Attribution 4.0. Download (140kB) | Preview |
Abstract
Biochemical assessment is recommended for patients prior to initiating and following a ketogenic diet (KD). There is no published literature regarding current practice in the UK and Ireland. We aimed to explore practice in comparison with international guidelines, determine approximate costs of biochemical testing in KD patients across the UK and Ireland, and promote greater consistency in KD services nationally. A survey was designed to determine the biochemical tests requested for patients at baseline, 3, 6, 12, 18, and 24 months + on KD. The survey was circulated to 39 centers across the UK and Ireland. Sixteen centers completed the survey. Full blood count, electrolytes, calcium, liver function tests (LFTs), lipid profile, and vitamin D were requested at all centers at baseline, in keeping with international guidelines. Bicarbonate, total protein, and urinalysis were less consistently requested. Magnesium and zinc were requested by all centers, despite not being specifically recommended for pre-diet evaluation in guidelines. Urea and electrolyte profiles and some LFTs were consistently requested at follow-up, in accordance with guidelines. Other LFTs and renal tests, full blood count, lipid profile, acylcarnitine profile, selenium, vitamin D, and urinalysis were less consistently requested at follow-up. The mean costs of the lowest and highest number of tests requested at baseline in our participating centers were £167.54 and £501.93; the mean costs of the lowest and highest number of tests requested at 3-month follow-up were £19.17 and £450.06. Biochemical monitoring of KD patients varies widely across the UK and Ireland and does not fully correspond to international best practice guidelines. With an ongoing drive for cost-effectiveness within health care, further work is needed to streamline practice while ensuring patient safety. [Abstract copyright: © 2019 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy.]
| Item Type: | Article |
|---|---|
| Additional Information: | ** From PubMed via Jisc Publications Router **Journal IDs: pissn 2470-9239 **Article IDs: pubmed: 32140645; pii: EPI412371; pmc: PMC7049795 **History: accepted 12-11-2019; revised 05-11-2019; submitted 21-06-2019 |
| Schools: | Schools > School of Health and Society |
| Journal or Publication Title: | Epilepsia Open |
| Publisher: | Wiley |
| ISSN: | 2470-9239 |
| Related URLs: | |
| SWORD Depositor: | Publications Router |
| Depositing User: | Publications Router |
| Date Deposited: | 20 Mar 2020 09:56 |
| Last Modified: | 16 Feb 2022 04:19 |
| URI: | http://usir.salford.ac.uk/id/eprint/56710 |
Actions (login required)
 |
Edit record (repository staff only) |
Tools
Tools